JP2011509916A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011509916A5 JP2011509916A5 JP2009546026A JP2009546026A JP2011509916A5 JP 2011509916 A5 JP2011509916 A5 JP 2011509916A5 JP 2009546026 A JP2009546026 A JP 2009546026A JP 2009546026 A JP2009546026 A JP 2009546026A JP 2011509916 A5 JP2011509916 A5 JP 2011509916A5
- Authority
- JP
- Japan
- Prior art keywords
- amino
- thiazolidine
- trifluorophenyl
- butanoyl
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 56
- 125000000217 alkyl group Chemical group 0.000 claims description 25
- 150000003839 salts Chemical group 0.000 claims description 23
- -1 morpholin-4-ylethyl Chemical group 0.000 claims description 21
- 229910052739 hydrogen Inorganic materials 0.000 claims description 18
- 239000001257 hydrogen Substances 0.000 claims description 18
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 18
- 239000000651 prodrug Chemical group 0.000 claims description 18
- 229940002612 prodrug Drugs 0.000 claims description 18
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 15
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 11
- 229910052760 oxygen Inorganic materials 0.000 claims description 7
- 125000001424 substituent group Chemical group 0.000 claims description 7
- 229910052717 sulfur Inorganic materials 0.000 claims description 7
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 6
- 150000002367 halogens Chemical class 0.000 claims description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims description 5
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 4
- 229910052736 halogen Inorganic materials 0.000 claims description 4
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 3
- 125000003118 aryl group Chemical group 0.000 claims description 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 2
- 125000005842 heteroatom Chemical group 0.000 claims description 2
- 125000002757 morpholinyl group Chemical group 0.000 claims description 2
- 125000004193 piperazinyl group Chemical group 0.000 claims description 2
- 125000003386 piperidinyl group Chemical group 0.000 claims description 2
- YDGXLVKDGGLWPF-UHFFFAOYSA-N 1,3-thiazolidine-2-carboxamide Chemical compound NC(=O)C1NCCS1 YDGXLVKDGGLWPF-UHFFFAOYSA-N 0.000 claims 58
- 150000001875 compounds Chemical class 0.000 claims 49
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims 19
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 12
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 11
- 102000016622 Dipeptidyl Peptidase 4 Human genes 0.000 claims 8
- 101000930822 Giardia intestinalis Dipeptidyl-peptidase 4 Proteins 0.000 claims 8
- 201000010099 disease Diseases 0.000 claims 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 6
- 230000001404 mediated effect Effects 0.000 claims 6
- 238000000034 method Methods 0.000 claims 5
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 4
- 208000002705 Glucose Intolerance Diseases 0.000 claims 3
- 208000008589 Obesity Diseases 0.000 claims 3
- 208000001132 Osteoporosis Diseases 0.000 claims 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims 3
- 206010003246 arthritis Diseases 0.000 claims 3
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 claims 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 3
- 235000020824 obesity Nutrition 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 201000009104 prediabetes syndrome Diseases 0.000 claims 3
- 208000035408 type 1 diabetes mellitus 1 Diseases 0.000 claims 3
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 3
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 claims 2
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 claims 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 2
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 claims 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 2
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 claims 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims 2
- SQZQMSWFFBQJNH-RSZJFWDMSA-N (2r)-2-[4-[[8-[3-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,3-thiazolidine-2-carbonyl]-1,4-dioxo-6,7,9,9a-tetrahydro-3h-pyrazino[1,2-a]pyrazin-2-yl]methyl]phenoxy]-3-methylbutanoic acid Chemical compound C1=CC(O[C@H](C(C)C)C(O)=O)=CC=C1CN1C(=O)C2CN(C(=O)C3N(CCS3)C(=O)C[C@H](N)CC=3C(=CC(F)=C(F)C=3)F)CCN2C(=O)C1 SQZQMSWFFBQJNH-RSZJFWDMSA-N 0.000 claims 1
- IDMQQXXSDWAOHU-PRESPHQNSA-N (2r)-2-[4-[[[3-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,3-thiazolidine-2-carbonyl]amino]methyl]phenoxy]-3-phenylpropanoic acid Chemical compound C([C@@H](OC1=CC=C(C=C1)CNC(=O)C1SCCN1C(=O)C[C@H](N)CC=1C(=CC(F)=C(F)C=1)F)C(O)=O)C1=CC=CC=C1 IDMQQXXSDWAOHU-PRESPHQNSA-N 0.000 claims 1
- YMHAVNUJTQOHLO-OQPBUACISA-N (2s)-3-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,3-thiazolidine-2-carboxylic acid Chemical compound C([C@H](N)CC=1C(=CC(F)=C(F)C=1)F)C(=O)N1CCS[C@H]1C(O)=O YMHAVNUJTQOHLO-OQPBUACISA-N 0.000 claims 1
- BTMYROPUHHEMJB-BSOCMFCZSA-N (3r)-3-amino-1-[2-(4-methylpiperazine-1-carbonyl)-1,3-thiazolidin-3-yl]-4-(2,4,5-trifluorophenyl)butan-1-one Chemical compound C1CN(C)CCN1C(=O)C1N(C(=O)C[C@H](N)CC=2C(=CC(F)=C(F)C=2)F)CCS1 BTMYROPUHHEMJB-BSOCMFCZSA-N 0.000 claims 1
- KKFNVIJVTFXTHJ-GKOGFXNCSA-N (3r)-3-amino-1-[2-(morpholine-4-carbonyl)-1,3-thiazolidin-3-yl]-4-(2,4,5-trifluorophenyl)butan-1-one Chemical compound C([C@H](N)CC=1C(=CC(F)=C(F)C=1)F)C(=O)N1CCSC1C(=O)N1CCOCC1 KKFNVIJVTFXTHJ-GKOGFXNCSA-N 0.000 claims 1
- LAUMNKKRZUPITH-GKOGFXNCSA-N (3r)-3-amino-1-[2-(piperazine-1-carbonyl)-1,3-thiazolidin-3-yl]-4-(2,4,5-trifluorophenyl)butan-1-one Chemical compound C([C@H](N)CC=1C(=CC(F)=C(F)C=1)F)C(=O)N1CCSC1C(=O)N1CCNCC1 LAUMNKKRZUPITH-GKOGFXNCSA-N 0.000 claims 1
- PJZFHYSDGZQUMG-GKOGFXNCSA-N (3r)-3-amino-1-[2-(thiomorpholine-4-carbonyl)-1,3-thiazolidin-3-yl]-4-(2,4,5-trifluorophenyl)butan-1-one Chemical compound C([C@H](N)CC=1C(=CC(F)=C(F)C=1)F)C(=O)N1CCSC1C(=O)N1CCSCC1 PJZFHYSDGZQUMG-GKOGFXNCSA-N 0.000 claims 1
- JIKZRWFMSWZOLP-UHFFFAOYSA-N 1,3-dioxole-2-carboxylic acid Chemical compound OC(=O)C1OC=CO1 JIKZRWFMSWZOLP-UHFFFAOYSA-N 0.000 claims 1
- OFYPGMVLIRMOKY-BSOCMFCZSA-N 1-[3-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,3-thiazolidine-2-carbonyl]piperidine-4-carboxylic acid Chemical compound C([C@H](N)CC=1C(=CC(F)=C(F)C=1)F)C(=O)N1CCSC1C(=O)N1CCC(C(O)=O)CC1 OFYPGMVLIRMOKY-BSOCMFCZSA-N 0.000 claims 1
- IIWKMMFEKKPJQI-NKTHEXPSSA-N 2-[3-[[[3-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,3-thiazolidine-2-carbonyl]amino]methyl]phenoxy]acetic acid Chemical compound C([C@H](N)CC=1C(=CC(F)=C(F)C=1)F)C(=O)N1CCSC1C(=O)NCC1=CC=CC(OCC(O)=O)=C1 IIWKMMFEKKPJQI-NKTHEXPSSA-N 0.000 claims 1
- NXKWJBXNSVGUHO-UWFASSMRSA-N 2-[4-[[3-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,3-thiazolidine-2-carbonyl]amino]piperidin-1-yl]-3-methylbutanoic acid Chemical compound C1CN(C(C(C)C)C(O)=O)CCC1NC(=O)C1N(C(=O)C[C@H](N)CC=2C(=CC(F)=C(F)C=2)F)CCS1 NXKWJBXNSVGUHO-UWFASSMRSA-N 0.000 claims 1
- QYYRKMWJQQAQSV-MWTRTKDXSA-N 2-[4-[[[(2s)-3-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,3-thiazolidine-2-carbonyl]amino]methyl]anilino]-2-methylpropanoic acid Chemical compound C1=CC(NC(C)(C)C(O)=O)=CC=C1CNC(=O)[C@H]1N(C(=O)C[C@H](N)CC=2C(=CC(F)=C(F)C=2)F)CCS1 QYYRKMWJQQAQSV-MWTRTKDXSA-N 0.000 claims 1
- WCAQLUWQIHPHIS-UEXBFKPASA-N 2-[4-[[[3-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,3-thiazolidine-2-carbonyl]-methylamino]methyl]phenoxy]-3-methylbutanoic acid Chemical compound C1=CC(OC(C(C)C)C(O)=O)=CC=C1CN(C)C(=O)C1N(C(=O)C[C@H](N)CC=2C(=CC(F)=C(F)C=2)F)CCS1 WCAQLUWQIHPHIS-UEXBFKPASA-N 0.000 claims 1
- STZGCLGKCFFUBH-NKTHEXPSSA-N 2-[4-[[[3-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,3-thiazolidine-2-carbonyl]amino]methyl]-2-fluorophenoxy]-2-methylpropanoic acid Chemical compound C1=C(F)C(OC(C)(C)C(O)=O)=CC=C1CNC(=O)C1N(C(=O)C[C@H](N)CC=2C(=CC(F)=C(F)C=2)F)CCS1 STZGCLGKCFFUBH-NKTHEXPSSA-N 0.000 claims 1
- QUWBPUIJKJQLDT-NKTHEXPSSA-N 2-[4-[[[3-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,3-thiazolidine-2-carbonyl]amino]methyl]-3-fluorophenoxy]-2-methylpropanoic acid Chemical compound FC1=CC(OC(C)(C)C(O)=O)=CC=C1CNC(=O)C1N(C(=O)C[C@H](N)CC=2C(=CC(F)=C(F)C=2)F)CCS1 QUWBPUIJKJQLDT-NKTHEXPSSA-N 0.000 claims 1
- RTXZHWSXDYQYRP-UOMYTMTESA-N 2-[4-[[[3-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,3-thiazolidine-2-carbonyl]amino]methyl]-3-fluorophenoxy]-3-methylbutanoic acid Chemical compound FC1=CC(OC(C(C)C)C(O)=O)=CC=C1CNC(=O)C1N(C(=O)C[C@H](N)CC=2C(=CC(F)=C(F)C=2)F)CCS1 RTXZHWSXDYQYRP-UOMYTMTESA-N 0.000 claims 1
- OXTGCEAIOCOHOO-UQEGFRFESA-N 2-[4-[[[3-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,3-thiazolidine-2-carbonyl]amino]methyl]-3-fluorophenoxy]butanoic acid Chemical compound FC1=CC(OC(CC)C(O)=O)=CC=C1CNC(=O)C1N(C(=O)C[C@H](N)CC=2C(=CC(F)=C(F)C=2)F)CCS1 OXTGCEAIOCOHOO-UQEGFRFESA-N 0.000 claims 1
- PKZVUKVLIUQYQI-UEXBFKPASA-N 2-[4-[[[3-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,3-thiazolidine-2-carbonyl]amino]methyl]-n-methylanilino]-3-methylbutanoic acid Chemical compound C1=CC(N(C)C(C(C)C)C(O)=O)=CC=C1CNC(=O)C1N(C(=O)C[C@H](N)CC=2C(=CC(F)=C(F)C=2)F)CCS1 PKZVUKVLIUQYQI-UEXBFKPASA-N 0.000 claims 1
- ZUNWVBNRQTWJFD-PAQRCMFQSA-N 2-[4-[[[3-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,3-thiazolidine-2-carbonyl]amino]methyl]anilino]-3-methylbutanoic acid Chemical compound C1=CC(NC(C(C)C)C(O)=O)=CC=C1CNC(=O)C1N(C(=O)C[C@H](N)CC=2C(=CC(F)=C(F)C=2)F)CCS1 ZUNWVBNRQTWJFD-PAQRCMFQSA-N 0.000 claims 1
- ZIXCRNJNDWBOCW-ADRQNKRLSA-N 2-[4-[[[3-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,3-thiazolidine-2-carbonyl]amino]methyl]phenoxy]-2-methylpropanoic acid Chemical compound C1=CC(OC(C)(C)C(O)=O)=CC=C1CNC(=O)C1N(C(=O)C[C@H](N)CC=2C(=CC(F)=C(F)C=2)F)CCS1 ZIXCRNJNDWBOCW-ADRQNKRLSA-N 0.000 claims 1
- YSCQSAINULPXKE-DKZXTENOSA-N 2-[4-[[[3-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,3-thiazolidine-2-carbonyl]amino]methyl]phenoxy]propanoic acid Chemical compound C1=CC(OC(C)C(O)=O)=CC=C1CNC(=O)C1N(C(=O)C[C@H](N)CC=2C(=CC(F)=C(F)C=2)F)CCS1 YSCQSAINULPXKE-DKZXTENOSA-N 0.000 claims 1
- FJJPDSRSWDECJJ-ADRQNKRLSA-N 2-[4-[[[3-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,3-thiazolidine-2-carbonyl]amino]methyl]phenyl]acetic acid Chemical compound C([C@H](N)CC=1C(=CC(F)=C(F)C=1)F)C(=O)N1CCSC1C(=O)NCC1=CC=C(CC(O)=O)C=C1 FJJPDSRSWDECJJ-ADRQNKRLSA-N 0.000 claims 1
- OJIWGFAXPREJST-FQEBHOFPSA-N 2-[[2-[3-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,3-thiazolidine-2-carbonyl]-3,4-dihydro-1h-isoquinolin-6-yl]oxy]-3-methylbutanoic acid Chemical compound C([C@@H](N)CC(=O)N1CCSC1C(=O)N1CC2=CC=C(C=C2CC1)OC(C(C)C)C(O)=O)C1=CC(F)=C(F)C=C1F OJIWGFAXPREJST-FQEBHOFPSA-N 0.000 claims 1
- QPVQUZRUJDJEIX-FQEBHOFPSA-N 2-[[2-[3-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,3-thiazolidine-2-carbonyl]-3,4-dihydro-1h-isoquinolin-7-yl]oxy]-3-methylbutanoic acid Chemical compound C([C@@H](N)CC(=O)N1CCSC1C(=O)N1CCC2=CC=C(C=C2C1)OC(C(C)C)C(O)=O)C1=CC(F)=C(F)C=C1F QPVQUZRUJDJEIX-FQEBHOFPSA-N 0.000 claims 1
- YMHAVNUJTQOHLO-UOGPZTOASA-N 3-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,3-thiazolidine-2-carboxylic acid Chemical compound C([C@H](N)CC=1C(=CC(F)=C(F)C=1)F)C(=O)N1CCSC1C(O)=O YMHAVNUJTQOHLO-UOGPZTOASA-N 0.000 claims 1
- AAGWKHSEAIXNGH-RBFZIWAESA-N 3-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-n-benzyl-1,3-thiazolidine-2-carboxamide Chemical compound C([C@H](N)CC=1C(=CC(F)=C(F)C=1)F)C(=O)N1CCSC1C(=O)NCC1=CC=CC=C1 AAGWKHSEAIXNGH-RBFZIWAESA-N 0.000 claims 1
- WNLAZJAMLUNUCR-ILRUXTBWSA-N 4-[[[3-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,3-thiazolidine-2-carbonyl]amino]methyl]-2-hydroxybenzoic acid Chemical compound C([C@H](N)CC=1C(=CC(F)=C(F)C=1)F)C(=O)N1CCSC1C(=O)NCC1=CC=C(C(O)=O)C(O)=C1 WNLAZJAMLUNUCR-ILRUXTBWSA-N 0.000 claims 1
- PMDWMNDMABSCTP-RBFZIWAESA-N 4-[[[3-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,3-thiazolidine-2-carbonyl]amino]methyl]benzoic acid Chemical compound C([C@H](N)CC=1C(=CC(F)=C(F)C=1)F)C(=O)N1CCSC1C(=O)NCC1=CC=C(C(O)=O)C=C1 PMDWMNDMABSCTP-RBFZIWAESA-N 0.000 claims 1
- QBWONUGOJGPKIR-VYTXHYLQSA-N 5-[[[3-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,3-thiazolidine-2-carbonyl]amino]methyl]-1,3-benzodioxole-2-carboxylic acid Chemical compound C([C@H](CC(=O)N1C(SCC1)C(=O)NCC=1C=C2OC(OC2=CC=1)C(O)=O)N)C1=CC(F)=C(F)C=C1F QBWONUGOJGPKIR-VYTXHYLQSA-N 0.000 claims 1
- YVONDORDYHTIHH-RLVCRIBASA-N 6-[[[3-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,3-thiazolidine-2-carbonyl]amino]methyl]-2,3-dihydro-1,4-benzodioxine-2-carboxylic acid Chemical compound C([C@H](CC(=O)N1C(SCC1)C(=O)NCC=1C=C2OCC(OC2=CC=1)C(O)=O)N)C1=CC(F)=C(F)C=C1F YVONDORDYHTIHH-RLVCRIBASA-N 0.000 claims 1
- IRBRJRYDYQPOHI-UHFFFAOYSA-N C(=O)=C1SCCN1 Chemical compound C(=O)=C1SCCN1 IRBRJRYDYQPOHI-UHFFFAOYSA-N 0.000 claims 1
- 102000004877 Insulin Human genes 0.000 claims 1
- 108090001061 Insulin Proteins 0.000 claims 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims 1
- IPBVNPXQWQGGJP-UHFFFAOYSA-N acetic acid phenyl ester Natural products CC(=O)OC1=CC=CC=C1 IPBVNPXQWQGGJP-UHFFFAOYSA-N 0.000 claims 1
- 125000002252 acyl group Chemical group 0.000 claims 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 125000005605 benzo group Chemical group 0.000 claims 1
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 claims 1
- 229910000024 caesium carbonate Inorganic materials 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000006482 condensation reaction Methods 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- MCJHRDLFDPIUGY-FPRIQVAYSA-N ethyl (2r)-2-[4-[[8-[3-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,3-thiazolidine-2-carbonyl]-1,4-dioxo-6,7,9,9a-tetrahydro-3h-pyrazino[1,2-a]pyrazin-2-yl]methyl]phenoxy]-3-methylbutanoate Chemical compound C1=CC(O[C@@H](C(=O)OCC)C(C)C)=CC=C1CN1C(=O)C2CN(C(=O)C3N(CCS3)C(=O)C[C@H](N)CC=3C(=CC(F)=C(F)C=3)F)CCN2C(=O)C1 MCJHRDLFDPIUGY-FPRIQVAYSA-N 0.000 claims 1
- CSXQHCUCOQQHHB-PAQRCMFQSA-N ethyl 2-[4-[[3-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,3-thiazolidine-2-carbonyl]amino]piperidin-1-yl]-3-methylbutanoate Chemical compound C1CN(C(C(C)C)C(=O)OCC)CCC1NC(=O)C1N(C(=O)C[C@H](N)CC=2C(=CC(F)=C(F)C=2)F)CCS1 CSXQHCUCOQQHHB-PAQRCMFQSA-N 0.000 claims 1
- NFMXJIQAIOKIIO-CJAUYULYSA-N ethyl 2-[4-[[[(2s)-3-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,3-thiazolidine-2-carbonyl]amino]methyl]anilino]-2-methylpropanoate Chemical compound C1=CC(NC(C)(C)C(=O)OCC)=CC=C1CNC(=O)[C@H]1N(C(=O)C[C@H](N)CC=2C(=CC(F)=C(F)C=2)F)CCS1 NFMXJIQAIOKIIO-CJAUYULYSA-N 0.000 claims 1
- OIBQLQNXRUNJHJ-SZYCOLMRSA-N ethyl 2-[4-[[[3-[(3r)-3-(1-acetyloxyethoxycarbonylamino)-4-(2,4,5-trifluorophenyl)butanoyl]-1,3-thiazolidine-2-carbonyl]amino]methyl]phenoxy]-3-methylbutanoate Chemical compound C1=CC(OC(C(=O)OCC)C(C)C)=CC=C1CNC(=O)C1N(C(=O)C[C@@H](CC=2C(=CC(F)=C(F)C=2)F)NC(=O)OC(C)OC(C)=O)CCS1 OIBQLQNXRUNJHJ-SZYCOLMRSA-N 0.000 claims 1
- DCIMFGRNSREIRY-SMFUYQKNSA-N ethyl 2-[4-[[[3-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,3-thiazolidine-2-carbonyl]amino]methyl]-2-fluorophenoxy]-2-methylpropanoate Chemical compound C1=C(F)C(OC(C)(C)C(=O)OCC)=CC=C1CNC(=O)C1N(C(=O)C[C@H](N)CC=2C(=CC(F)=C(F)C=2)F)CCS1 DCIMFGRNSREIRY-SMFUYQKNSA-N 0.000 claims 1
- WHPBHSOUBGTORM-SMFUYQKNSA-N ethyl 2-[4-[[[3-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,3-thiazolidine-2-carbonyl]amino]methyl]-3-fluorophenoxy]-2-methylpropanoate Chemical compound FC1=CC(OC(C)(C)C(=O)OCC)=CC=C1CNC(=O)C1N(C(=O)C[C@H](N)CC=2C(=CC(F)=C(F)C=2)F)CCS1 WHPBHSOUBGTORM-SMFUYQKNSA-N 0.000 claims 1
- AKFDKXQYMSXKAU-UPMSZNRZSA-N ethyl 2-[4-[[[3-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,3-thiazolidine-2-carbonyl]amino]methyl]-3-fluorophenoxy]-3-methylbutanoate Chemical compound FC1=CC(OC(C(=O)OCC)C(C)C)=CC=C1CNC(=O)C1N(C(=O)C[C@H](N)CC=2C(=CC(F)=C(F)C=2)F)CCS1 AKFDKXQYMSXKAU-UPMSZNRZSA-N 0.000 claims 1
- NLWGNYWZJHVFHZ-JRHFUVFWSA-N ethyl 2-[4-[[[3-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,3-thiazolidine-2-carbonyl]amino]methyl]-n-methylanilino]-3-methylbutanoate Chemical compound C1=CC(N(C)C(C(C)C)C(=O)OCC)=CC=C1CNC(=O)C1N(C(=O)C[C@H](N)CC=2C(=CC(F)=C(F)C=2)F)CCS1 NLWGNYWZJHVFHZ-JRHFUVFWSA-N 0.000 claims 1
- YXBDCYDMXMSFAK-FQEBHOFPSA-N ethyl 2-[4-[[[3-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,3-thiazolidine-2-carbonyl]amino]methyl]anilino]-3-methylbutanoate Chemical compound C1=CC(NC(C(=O)OCC)C(C)C)=CC=C1CNC(=O)C1N(C(=O)C[C@H](N)CC=2C(=CC(F)=C(F)C=2)F)CCS1 YXBDCYDMXMSFAK-FQEBHOFPSA-N 0.000 claims 1
- IRCGPLRKGXDPQB-UGSZZNERSA-N ethyl 2-[[2-[3-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,3-thiazolidine-2-carbonyl]-3,4-dihydro-1h-isoquinolin-6-yl]oxy]-3-methylbutanoate Chemical compound C([C@@H](N)CC(=O)N1CCSC1C(=O)N1CC2=CC=C(C=C2CC1)OC(C(=O)OCC)C(C)C)C1=CC(F)=C(F)C=C1F IRCGPLRKGXDPQB-UGSZZNERSA-N 0.000 claims 1
- DUEXFHBNSRGHCO-UGSZZNERSA-N ethyl 2-[[2-[3-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,3-thiazolidine-2-carbonyl]-3,4-dihydro-1h-isoquinolin-7-yl]oxy]-3-methylbutanoate Chemical compound C([C@@H](N)CC(=O)N1CCSC1C(=O)N1CCC2=CC=C(C=C2C1)OC(C(=O)OCC)C(C)C)C1=CC(F)=C(F)C=C1F DUEXFHBNSRGHCO-UGSZZNERSA-N 0.000 claims 1
- SOOMSOFJGXDQPT-PKZZPTEUSA-N ethyl 6-[[[3-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,3-thiazolidine-2-carbonyl]amino]methyl]-2,3-dihydro-1,4-benzodioxine-2-carboxylate Chemical compound C([C@@H](N)CC(=O)N1CCSC1C(=O)NCC=1C=C2OCC(OC2=CC=1)C(=O)OCC)C1=CC(F)=C(F)C=C1F SOOMSOFJGXDQPT-PKZZPTEUSA-N 0.000 claims 1
- 239000001530 fumaric acid Substances 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 229940125396 insulin Drugs 0.000 claims 1
- 239000004310 lactic acid Substances 0.000 claims 1
- 235000014655 lactic acid Nutrition 0.000 claims 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims 1
- 239000011976 maleic acid Substances 0.000 claims 1
- 229940098779 methanesulfonic acid Drugs 0.000 claims 1
- RUZLIIJDZBWWSA-INIZCTEOSA-N methyl 2-[[(1s)-1-(7-methyl-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidin-9-yl)ethyl]amino]benzoate Chemical group COC(=O)C1=CC=CC=C1N[C@@H](C)C1=CC(C)=CN2C(=O)C=C(N3CCOCC3)N=C12 RUZLIIJDZBWWSA-INIZCTEOSA-N 0.000 claims 1
- ZESMCYXZKZIVNF-HNNQXCQYSA-N methyl 4-[[[3-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,3-thiazolidine-2-carbonyl]amino]methyl]-2-hydroxybenzoate Chemical compound C1=C(O)C(C(=O)OC)=CC=C1CNC(=O)C1N(C(=O)C[C@H](N)CC=2C(=CC(F)=C(F)C=2)F)CCS1 ZESMCYXZKZIVNF-HNNQXCQYSA-N 0.000 claims 1
- 229940049953 phenylacetate Drugs 0.000 claims 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 claims 1
- 235000015497 potassium bicarbonate Nutrition 0.000 claims 1
- 239000011736 potassium bicarbonate Substances 0.000 claims 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 1
- 238000001953 recrystallisation Methods 0.000 claims 1
- ULSZVNJBVJWEJE-UHFFFAOYSA-N thiazolidine-2-carboxylic acid Chemical compound OC(=O)C1NCCS1 ULSZVNJBVJWEJE-UHFFFAOYSA-N 0.000 claims 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- ONIKNECPXCLUHT-UHFFFAOYSA-N 2-chlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1Cl ONIKNECPXCLUHT-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- 0 C*CSCCN Chemical compound C*CSCCN 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical group C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020070004577A KR100848491B1 (ko) | 2007-01-16 | 2007-01-16 | 베타아미노기를 갖는 2-싸이아졸리딘 유도체, 이의약학적으로 허용 가능한 염 및 이의 제조 방법 |
| PCT/IB2008/000773 WO2008087560A2 (en) | 2007-01-16 | 2008-01-16 | Thiazolidine derivatives and methods for the preparation thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011509916A JP2011509916A (ja) | 2011-03-31 |
| JP2011509916A5 true JP2011509916A5 (enExample) | 2011-05-12 |
Family
ID=39588017
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009546026A Pending JP2011509916A (ja) | 2007-01-16 | 2008-01-16 | チアゾリジン誘導体およびその製造方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20100048570A1 (enExample) |
| EP (1) | EP2118081A2 (enExample) |
| JP (1) | JP2011509916A (enExample) |
| KR (2) | KR100848491B1 (enExample) |
| CN (1) | CN101720319A (enExample) |
| AU (1) | AU2008206702A1 (enExample) |
| BR (1) | BRPI0806592A2 (enExample) |
| CA (1) | CA2712109A1 (enExample) |
| IL (1) | IL199892A0 (enExample) |
| MX (1) | MX2009007630A (enExample) |
| WO (1) | WO2008087560A2 (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7767657B2 (en) | 2005-02-16 | 2010-08-03 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
| SI3424932T1 (sl) | 2005-02-16 | 2021-08-31 | Anacor Pharmaceuticals, Inc. | Boronoftalidi za terapevtsko uporabo |
| HRP20150710T1 (hr) | 2006-02-16 | 2015-08-14 | Anacor Pharmaceuticals, Inc. | Male molekule koje sadrže bor kao protu-upalni agensi |
| RU2015109165A (ru) | 2008-03-06 | 2015-11-10 | Анакор Фармасьютикалз, Инк. | Борсодержащие малые молекулы в качестве противовоспалительных агентов |
| WO2010027975A1 (en) * | 2008-09-04 | 2010-03-11 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
| WO2010028005A1 (en) * | 2008-09-04 | 2010-03-11 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
| EP2415753B1 (en) | 2009-03-30 | 2014-08-27 | Dong-A Pharmaceutical Co., Ltd. | Method for preparing dipeptidyl peptidase-iv inhibitor and intermediate |
| BRPI1014070B8 (pt) | 2009-03-30 | 2021-05-25 | Dong A Pharm Co Ltd | processos para a produção de inibidor de dipeptidil peptidase-iv e intermediário |
| US9440994B2 (en) | 2009-08-14 | 2016-09-13 | Anacor Pharmaceuticals, Inc. | Boron containing small molecules as antiprotozoal agents |
| US9346834B2 (en) | 2009-10-20 | 2016-05-24 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as antiprotozoal agents |
| WO2011060199A1 (en) * | 2009-11-11 | 2011-05-19 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
| WO2011094450A1 (en) | 2010-01-27 | 2011-08-04 | Anacor Pharmaceuticals, Inc | Boron-containing small molecules |
| WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| US8623911B2 (en) | 2010-03-19 | 2014-01-07 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as anti-protozoal agent |
| EP2555625B1 (en) | 2010-04-07 | 2018-11-14 | GlaxoSmithKline LLC | Process for preparing benzoxaboroles |
| EP2582709B1 (de) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
| US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
| TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
| TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
| PT3251678T (pt) | 2010-09-07 | 2021-11-22 | Anacor Pharmaceuticals Inc | Derivados de benzoxaborol para tratamento de infeções bacterianas |
| WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| WO2013045413A1 (en) | 2011-09-27 | 2013-04-04 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| WO2014064215A1 (en) | 2012-10-24 | 2014-05-01 | INSERM (Institut National de la Santé et de la Recherche Médicale) | TPL2 KINASE INHIBITORS FOR PREVENTING OR TREATING DIABETES AND FOR PROMOTING β-CELL SURVIVAL |
| CN103122009B (zh) * | 2013-01-09 | 2015-11-25 | 江苏吉贝尔药业股份有限公司 | 两种用于合成他卡西醇支链的重要中间体化合物 |
| CN103012463B (zh) * | 2013-01-17 | 2016-02-10 | 南京理工大学 | (s)-3-甲基-2-(叔丁基二甲基硅氧基)-1-溴丁烷的合成方法 |
| EP4029870A1 (en) | 2013-08-09 | 2022-07-20 | GlaxoSmithKline Intellectual Property (No.2) Limited | Tricyclic benzoxaborole compounds and uses thereof |
| MA41494B1 (fr) | 2015-02-12 | 2020-10-28 | Glaxosmithkline Ip No 2 Ltd | Composés benzoxaborole substitués en position 4 et utilisations associées |
| ES2805743T3 (es) | 2015-03-24 | 2021-02-15 | Inst Nat Sante Rech Med | Método y composición farmacéutica para uso en el tratamiento de la diabetes |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL111785A0 (en) * | 1993-12-03 | 1995-01-24 | Ferring Bv | Dp-iv inhibitors and pharmaceutical compositions containing them |
| AU2790895A (en) * | 1994-06-10 | 1996-01-05 | Universitaire Instelling Antwerpen | Purification of serine protease and synthetic inhibitors thereof |
| CA2390231A1 (en) * | 1999-11-12 | 2001-05-17 | Paul Jackson | Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors |
| FR2824825B1 (fr) * | 2001-05-15 | 2005-05-06 | Servier Lab | Nouveaux derives d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| JP2004535433A (ja) * | 2001-06-20 | 2004-11-25 | メルク エンド カムパニー インコーポレーテッド | 糖尿病治療用のジペプチジルペプチダーゼ阻害薬 |
| WO2003057144A2 (en) * | 2001-12-26 | 2003-07-17 | Guilford Pharmaceuticals | Change inhibitors of dipeptidyl peptidase iv |
| EP1562925B1 (en) * | 2002-11-07 | 2007-01-03 | Merck & Co., Inc. | Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| CA2508487A1 (en) * | 2002-12-04 | 2004-06-17 | Merck & Co., Inc. | Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| AP2007003973A0 (en) * | 2004-10-12 | 2007-07-30 | Glenmark Pharmaceuticals Sa | Novel dideptidyl peptidase IV inhibitors, pharmaceutical compositions containing them, and proces for their preparation |
-
2007
- 2007-01-16 KR KR1020070004577A patent/KR100848491B1/ko not_active Expired - Fee Related
-
2008
- 2008-01-16 KR KR1020097017134A patent/KR20100094337A/ko not_active Withdrawn
- 2008-01-16 BR BRPI0806592-6A2A patent/BRPI0806592A2/pt not_active IP Right Cessation
- 2008-01-16 MX MX2009007630A patent/MX2009007630A/es not_active Application Discontinuation
- 2008-01-16 CA CA2712109A patent/CA2712109A1/en not_active Abandoned
- 2008-01-16 AU AU2008206702A patent/AU2008206702A1/en not_active Abandoned
- 2008-01-16 US US12/523,285 patent/US20100048570A1/en not_active Abandoned
- 2008-01-16 WO PCT/IB2008/000773 patent/WO2008087560A2/en not_active Ceased
- 2008-01-16 EP EP08719395A patent/EP2118081A2/en not_active Withdrawn
- 2008-01-16 CN CN200880007800A patent/CN101720319A/zh active Pending
- 2008-01-16 JP JP2009546026A patent/JP2011509916A/ja active Pending
-
2009
- 2009-07-16 IL IL199892A patent/IL199892A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011509916A5 (enExample) | ||
| JP2011509916A (ja) | チアゾリジン誘導体およびその製造方法 | |
| JP2007537187A5 (enExample) | ||
| JP2007502806A5 (enExample) | ||
| JP2005539045A5 (enExample) | ||
| JP2010526146A5 (enExample) | ||
| CA2451393A1 (en) | 2 pyrrolidone derivatives as prostanoid agonists | |
| JP2011513367A5 (enExample) | ||
| JP2007502264A5 (enExample) | ||
| JP2004533450A5 (enExample) | ||
| JP2006509749A5 (enExample) | ||
| JP2020527175A5 (enExample) | ||
| JPH10279578A5 (enExample) | ||
| RU2007116317A (ru) | Гексафторизопропанол-замещенные производные простых эфиров | |
| JP2009543795A5 (enExample) | ||
| JP2007502265A5 (enExample) | ||
| JP2008508247A5 (enExample) | ||
| JP2005526696A5 (enExample) | ||
| JP2005514452A5 (enExample) | ||
| JP2008509950A5 (enExample) | ||
| JP2010535706A5 (enExample) | ||
| JP2004517151A5 (enExample) | ||
| JP2008520737A5 (enExample) | ||
| JP2012509313A5 (enExample) | ||
| JP2013532682A5 (enExample) |